Evaluation of Stigma and Related Factors in Fibromyalgia
NCT ID: NCT04274036
Last Updated: 2020-02-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
108 participants
OBSERVATIONAL
2020-02-13
2020-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pain Severity in Fibromyalgia Syndrome
NCT05481086
The Relationship Between Fibromyalgia Syndrome Parameters With Disease-Pain Severity and the Quality Of Life
NCT05850442
The Effect of Positive Psychotherapy Based Psychoeducation on Pain Perception With Fibromyalgia Syndrome
NCT06147882
Fibromyalgia Syndrome on Patients With Chronic Migraine
NCT05381012
Effects of the COVID-19 Pandemic on Fibromyalgia Patients
NCT04730934
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fibromyalgia Patients
Fibromyalgia patients diagnosed according to the 2016 American College of Rheumatology criteria.
No interventions assigned to this group
Healthy-Controls
Healthy controls without pain or chronic illness
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* To be diagnosed with fibromyalgia according to American College of Rheumatology 2016 revised criteria
Exclusion Criteria
* Presence of any diagnosis that can cause secondary fibromyalgia (rheumatic diseases such as rheumatoid arthritis, ankylosing spondylitis)
* The presence of anemia
* Vitamin D deficiency
* Presence of known endocrine, neurological and cardiac diseases
* Antidepressant use
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gaziosmanpasa Research and Education Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mehmet Akif GÜLER
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gaziosmanpasa Taksim Research and Education Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.